Tone mix
Week by week 52 weeks
Share of Novo-Nordisk A/S's 2,375 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Dec 22, 2025 · tone +72Biotech Stocks Shine After Hours: Novo Nordisk, IDEAYA, Healthcare Triangle Among Gainers+74
- Week of Jun 15, 2026 · tone -46Hacking group claims major hack of Novo Nordisk and attempted $25 million extortion-70
- Week of Apr 13, 2026 · tone +52Novo Nordisk signs deal with OpenAI to develop new drugs+50
- Week of Feb 2, 2026 · tone -34Hims & Hers launches copy of Wegovy pill, prompting legal threats from drugmaker Novo Nordisk-47
- Week of Jun 1, 2026 · tone +3Baystreet.ca - Why Comcast, Bonds, and Novo Nordisk Keep Falling-42
- Week of Apr 20, 2026 · tone +61Novo Nordisk Announces Partnership with OpenAI+42
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Novo-Nordisk A/S in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 28 | +37 |
| Last 30 sessions | 105 | +23 |
| Last 90 sessions | 504 | +9 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Friday, November 6, 2026
4 headlines, average tone +25: 1 positive, 3 neutral and 0 negative. Showing all 4.
- www.foreignpolicyjournal.com · 1 outletNovo Nordisk (NYSE: NVO) Stock Surges Nearly 5% As Pipeline Drug Shows 12.4% Weight Loss In TrialPositive
- seekingalpha.com · 1 outletGinkgo reaffirms 2026 cash burn guidance of $125M-$150M while outlining first pharma autonomous lab sale to Novo Nordisk (NYSE:DNA)Neutral
- econotimes.com · 1 outletNovo Nordisk R&D Chief Sold 12,000 Shares for DKK 3.42 MillionNeutral
- www.investegate.co.uk · 1 outletNovo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons | Company AnnouncementNeutral
Show the table · 4 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Novo Nordisk (NYSE: NVO) Stock Surges Nearly 5% As Pipeline Drug Shows 12.4% Weight Loss In Trial | www.foreignpolicyjournal.com | 1 | Positive |
| Ginkgo reaffirms 2026 cash burn guidance of $125M-$150M while outlining first pharma autonomous lab sale to Novo Nordisk (NYSE:DNA) | seekingalpha.com | 1 | Neutral |
| Novo Nordisk R&D Chief Sold 12,000 Shares for DKK 3.42 Million | econotimes.com | 1 | Neutral |
| Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons | Company Announcement | www.investegate.co.uk | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, November 5, 2026
10 headlines, average tone +21: 4 positive, 4 neutral and 2 negative. The 8 most widely carried stories are listed; the table holds all 10.
- www.aol.com · 2 outletsNovo Nordisk Stock Jumps 6% as Wegovy Hits a Stunning 80% MilestonePositive
- www.businesspost.ie · 1 outletWeight loss sales gain: Finally a tailwind for Novo NordiskPositive
- cphpost.dk · 1 outletNovo Nordisk raises sales forecast - The Copenhagen PostPositive
- www.thenews.com.pk · 1 outletNovo Nordisk loses share in Brazil as cheaper rivals gain market shareNegative
- www.foreignpolicyjournal.com · 1 outletGENFIT's (Euronext: GNFT) MASH Diagnostic Tool Draws Novo Nordisk, Eli Lilly And Madrigal As Medicare Coverage Milestone Reshapes Treatment LandscapePositive
- www.proactiveinvestors.com · 1 outletNovo Nordisk outlook upgrade leaves forecasts lagging, Jefferies saysNegative
- www.fool.com · 1 outletNovo Nordisk: 3 Key Takeaways for Long-Term InvestorsNeutral
- www.aol.com · 1 outletNovo Nordisk CEO says CVS breakup has no material impact on the weight-loss drug giantNeutral
Show the table · 10 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Novo Nordisk Stock Jumps 6% as Wegovy Hits a Stunning 80% Milestone | www.aol.com | 2 | Positive |
| Weight loss sales gain: Finally a tailwind for Novo Nordisk | www.businesspost.ie | 1 | Positive |
| Novo Nordisk raises sales forecast - The Copenhagen Post | cphpost.dk | 1 | Positive |
| Novo Nordisk loses share in Brazil as cheaper rivals gain market share | www.thenews.com.pk | 1 | Negative |
| GENFIT's (Euronext: GNFT) MASH Diagnostic Tool Draws Novo Nordisk, Eli Lilly And Madrigal As Medicare Coverage Milestone Reshapes Treatment Landscape | www.foreignpolicyjournal.com | 1 | Positive |
| Novo Nordisk outlook upgrade leaves forecasts lagging, Jefferies says | www.proactiveinvestors.com | 1 | Negative |
| Novo Nordisk: 3 Key Takeaways for Long-Term Investors | www.fool.com | 1 | Neutral |
| Novo Nordisk CEO says CVS breakup has no material impact on the weight-loss drug giant | www.aol.com | 1 | Neutral |
| Novo Nordisk (NVO) Q3 2026 Earnings Call Transcript | www.fool.com | 1 | Neutral |
| Stocks making the biggest moves premarket: DJT, TSLA, CRWV, NVO | www.cnbc.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, November 4, 2026
9 headlines, average tone +78: 7 positive, 2 neutral and 0 negative. The 8 most widely carried stories are listed; the table holds all 9.
- www.rttnews.com · 2 outletsNovo Nordisk Q3 Adj. Operating Profit Increases, Obesity Sales Up 22%; Raises 2026 OutlookPositive
- econotimes.com · 1 outletNovo Nordisk Raises 2026 Outlook as Obesity Sales Climb 22%Positive
- www.freemalaysiatoday.com · 1 outletNovo Nordisk's Wegovy pill beats forecasts as it battles LillyPositive
- www.aol.com · 1 outletEuropean shares rise as Democrats take US Congress, Novo Nordisk surgesPositive
- www.rttnews.com · 1 outletNovo Nordisk Raises Full-Year Outlook As GLP-1 Portfolio Continues To Drive GrowthPositive
- www.rte.ie · 1 outletNovo Nordisk hikes 2026 outlook againPositive
- economictimes.indiatimes.com · 1 outletEuropean shares rise as banks, clean energy stocks rally; Novo Nordisk jumpsPositive
- ipwatchdog.com · 1 outletThe UPC Marks the Edge of Its Own Jurisdiction in Sandoz v. Novo NordiskNeutral
Show the table · 9 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Novo Nordisk Q3 Adj. Operating Profit Increases, Obesity Sales Up 22%; Raises 2026 Outlook | www.rttnews.com | 2 | Positive |
| Novo Nordisk Raises 2026 Outlook as Obesity Sales Climb 22% | econotimes.com | 1 | Positive |
| Novo Nordisk's Wegovy pill beats forecasts as it battles Lilly | www.freemalaysiatoday.com | 1 | Positive |
| European shares rise as Democrats take US Congress, Novo Nordisk surges | www.aol.com | 1 | Positive |
| Novo Nordisk Raises Full-Year Outlook As GLP-1 Portfolio Continues To Drive Growth | www.rttnews.com | 1 | Positive |
| Novo Nordisk hikes 2026 outlook again | www.rte.ie | 1 | Positive |
| European shares rise as banks, clean energy stocks rally; Novo Nordisk jumps | economictimes.indiatimes.com | 1 | Positive |
| The UPC Marks the Edge of Its Own Jurisdiction in Sandoz v. Novo Nordisk | ipwatchdog.com | 1 | Neutral |
| Novo Nordisk A/S - share repurchase programme | Company Announcement | www.investegate.co.uk | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, November 3, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.foreignpolicyjournal.com · 1 outletNovo Nordisk (NYSE: NVO) Stock Trades At A Fraction Of Sector Peers As Valuation Gap WidensNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Novo Nordisk (NYSE: NVO) Stock Trades At A Fraction Of Sector Peers As Valuation Gap Widens | www.foreignpolicyjournal.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, November 2, 2026
2 headlines, average tone +46: 1 positive, 1 neutral and 0 negative. Showing all 2.
- www.fool.com · 3 outletsNovo Nordisk Trades at 10 Times Earnings While Buying Back Billions in Stock. Is This the Bottom?Positive
- www.foreignpolicyjournal.com · 1 outletLilly's Retatrutide Delivers Double The Weight Loss Of Ozempic, Raising Competitive Stakes For Novo Nordisk (NYSE: NVO)Neutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Novo Nordisk Trades at 10 Times Earnings While Buying Back Billions in Stock. Is This the Bottom? | www.fool.com | 3 | Positive |
| Lilly's Retatrutide Delivers Double The Weight Loss Of Ozempic, Raising Competitive Stakes For Novo Nordisk (NYSE: NVO) | www.foreignpolicyjournal.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Novo-Nordisk A/S, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.